EE04440B1 - Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon - Google Patents

Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon

Info

Publication number
EE04440B1
EE04440B1 EEP200000370A EEP200000370A EE04440B1 EE 04440 B1 EE04440 B1 EE 04440B1 EE P200000370 A EEP200000370 A EE P200000370A EE P200000370 A EEP200000370 A EE P200000370A EE 04440 B1 EE04440 B1 EE 04440B1
Authority
EE
Estonia
Prior art keywords
capareceptor
pharmaceutical composition
opioid peptides
opioid
peptides
Prior art date
Application number
EEP200000370A
Other languages
English (en)
Estonian (et)
Inventor
Louis Junien Jean
J. M. Riviere Pierre
D. Schteingart Claudio
Sueiras Diaz Javier
A. Trojnar Jerzy
W. Vanderah Todd
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of EE200000370A publication Critical patent/EE200000370A/xx
Publication of EE04440B1 publication Critical patent/EE04440B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000370A 1997-12-23 1998-12-22 Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon EE04440B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (fr) 1997-12-23 1998-12-22 Peptides recepteurs opioides kappa

Publications (2)

Publication Number Publication Date
EE200000370A EE200000370A (et) 2001-10-15
EE04440B1 true EE04440B1 (et) 2005-02-15

Family

ID=25543752

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000370A EE04440B1 (et) 1997-12-23 1998-12-22 Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon

Country Status (33)

Country Link
US (1) US5965701A (fr)
EP (1) EP1042359B1 (fr)
JP (1) JP4275852B2 (fr)
KR (1) KR100629548B1 (fr)
CN (1) CN1154655C (fr)
AR (1) AR014167A1 (fr)
AT (1) ATE301670T1 (fr)
AU (1) AU747806B2 (fr)
BR (2) BR9814499B1 (fr)
CA (1) CA2315878C (fr)
CR (1) CR5936A (fr)
CZ (1) CZ297281B6 (fr)
DE (1) DE69831176T2 (fr)
DK (1) DK1042359T3 (fr)
EE (1) EE04440B1 (fr)
ES (1) ES2247735T3 (fr)
HK (1) HK1029349A1 (fr)
HR (1) HRP20000415B1 (fr)
HU (1) HU227640B1 (fr)
IL (3) IL136742A0 (fr)
MY (1) MY117542A (fr)
NO (1) NO327080B1 (fr)
NZ (1) NZ505183A (fr)
PL (1) PL195842B1 (fr)
PT (1) PT1042359E (fr)
RU (1) RU2217437C2 (fr)
SK (1) SK286135B6 (fr)
TR (1) TR200001985T2 (fr)
TW (1) TW580502B (fr)
UA (1) UA68366C2 (fr)
UY (1) UY25327A1 (fr)
WO (1) WO1999032510A1 (fr)
ZA (1) ZA9811801B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
CA2451133C (fr) * 2001-05-08 2012-09-18 Toray Industries, Inc. Agent therapeutique contre la sepsie
EP1894591B1 (fr) 2002-03-20 2013-06-26 MannKind Corporation Cartouche pour un appareil d'inhalation
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
HUE028623T2 (en) 2005-09-14 2016-12-28 Mannkind Corp Active substance formulation method based on increasing the affinity of the active ingredient for binding to the surface of crystalline microparticles
IN2015DN00888A (fr) 2006-02-22 2015-07-10 Mannkind Corp
CA2653077A1 (fr) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. N-oxydes de peptides de recepteurs de kappa-opioides
CN101454017A (zh) * 2006-05-26 2009-06-10 卡拉治疗学股份有限公司 提升哺乳动物催乳素的方法
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
BRPI0718651B8 (pt) * 2006-11-10 2021-05-25 Cara Therapeutics Inc amidas peptídicas sintéticas
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
WO2008077194A1 (fr) * 2006-12-22 2008-07-03 Xenome Ltd Agonistes de récepteurs
ES2570400T3 (es) 2008-06-13 2016-05-18 Mannkind Corp Un inhalador de polvo seco y un sistema para el suministro de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2405963B1 (fr) 2009-03-11 2013-11-06 MannKind Corporation Appareil, système et procédé de mesure de résistance d'un inhalateur
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
CN103945859A (zh) * 2011-10-24 2014-07-23 曼金德公司 用于治疗疼痛的方法和组合物
WO2014012069A2 (fr) 2012-07-12 2014-01-16 Mannkind Corporation Systèmes et procédés de libération de médicament en poudre sèche
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
ES2715082T3 (es) * 2014-06-26 2019-05-31 Maruishi Pharma Método de producción de un pentapéptido sintético
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2016181408A2 (fr) 2015-05-11 2016-11-17 Cadila Healthcare Limited Nouveaux peptides à chaîne courte en tant qu'agonistes des récepteurs opioïdes kappa (κ) (kor)
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
EP3521301B1 (fr) * 2016-09-27 2024-03-06 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Composé polyamide et son utilisation
WO2019015644A1 (fr) * 2017-07-21 2019-01-24 四川海思科制药有限公司 Composé amide peptidique, son procédé de préparation et son utilisation médicale
JP2021505596A (ja) 2017-12-06 2021-02-18 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司Ｊｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．， Ｌｔｄ． フェニルプロピオンアミド誘導体の塩およびその製造方法
CA3095966A1 (fr) 2018-05-16 2019-11-21 Jiangsu Hengrui Medicine Co., Ltd. Composition pharmaceutique d'agoniste du recepteur kor
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
CN114127086B (zh) * 2019-07-25 2023-10-20 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
US20210040150A1 (en) * 2019-08-07 2021-02-11 Humanwell Pharmaceutical US Kappa opioid receptor peptide amide agonists
KR20230024419A (ko) 2020-06-25 2023-02-20 휴먼웰 파마슈티컬 유에스 의학적 장애 치료용 펩티드
WO2023278843A2 (fr) 2021-07-02 2023-01-05 Acer Therapeutics, Inc. Formes solides d'osanétant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
PT1042359E (pt) 2005-11-30
ATE301670T1 (de) 2005-08-15
CR5936A (es) 2006-08-18
BR9814499B1 (pt) 2014-10-21
BRPI9814499B1 (pt) 2014-10-21
KR20010033450A (ko) 2001-04-25
BRPI9814499A (pt) 2000-10-10
JP4275852B2 (ja) 2009-06-10
ZA9811801B (en) 1999-06-22
EP1042359B1 (fr) 2005-08-10
HRP20000415A2 (en) 2000-12-31
TW580502B (en) 2004-03-21
EE200000370A (et) 2001-10-15
CA2315878C (fr) 2010-11-16
HUP0100626A3 (en) 2001-12-28
WO1999032510A1 (fr) 1999-07-01
NO327080B1 (no) 2009-04-20
WO1999032510A9 (fr) 1999-09-23
AU747806B2 (en) 2002-05-23
PL341308A1 (en) 2001-04-09
ES2247735T3 (es) 2006-03-01
CN1283201A (zh) 2001-02-07
SK9602000A3 (en) 2001-01-18
CZ297281B6 (cs) 2006-10-11
HUP0100626A2 (hu) 2001-08-28
HK1029349A1 (en) 2001-03-30
AR014167A1 (es) 2001-02-07
IL136742A0 (en) 2001-06-14
DK1042359T3 (da) 2005-11-28
NO20003245D0 (no) 2000-06-21
JP2001526295A (ja) 2001-12-18
AU1940299A (en) 1999-07-12
NO20003245L (no) 2000-08-23
BRPI9814499B8 (pt) 2021-11-09
PL195842B1 (pl) 2007-10-31
NZ505183A (en) 2001-09-28
RU2217437C2 (ru) 2003-11-27
US5965701A (en) 1999-10-12
BR9814499A (pt) 2000-10-10
UY25327A1 (es) 2000-12-29
UA68366C2 (en) 2004-08-16
DE69831176D1 (de) 2005-09-15
HU227640B1 (en) 2011-10-28
TR200001985T2 (tr) 2000-11-21
KR100629548B1 (ko) 2006-09-27
MY117542A (en) 2004-07-31
CN1154655C (zh) 2004-06-23
DE69831176T2 (de) 2006-04-20
IL178471A0 (en) 2007-02-11
EP1042359A1 (fr) 2000-10-11
HRP20000415B1 (en) 2004-06-30
IL136742A (en) 2006-12-31
CZ20002382A3 (cs) 2000-12-13
SK286135B6 (sk) 2008-04-07
CA2315878A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
EE04294B1 (et) Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
DK0920302T4 (da) Farmaceutisk aerosolsammensætning
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
PT881906E (pt) Composicao farmaceutica para a imunomodelacao baseada em peptideos e adjuvantes
ID24654A (id) Formulasi farmasi omeprazola
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
NO980546D0 (no) Farmasöytiske midler
EE04001B1 (et) Peptiidne farmatseutiline kompositsioon
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
BR9509688A (pt) Composto e composição farmacêutica
HUP0003189A2 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
ID29294A (id) Komposisi farmasi
ATE208364T1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
ID25857A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
BR9710568A (pt) Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
BR9505130A (pt) Composto e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20121222